United Kingdom
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 37.77 B
|
Dec. 31, 2023 | USD 140.24 | -0.22% |
|
United Kingdom |
|
2 |
USD 27.69 B
|
Dec. 31, 2023 | USD 17.39 | -0.08% |
|
United Kingdom |
|
3 |
USD 8.58 B
|
Dec. 31, 2023 | USD 4.67 | 0.65% |
|
United Kingdom |
|
4 |
USD 3.89 B
|
Dec. 31, 2023 | USD 12.79 | 0.04% |
|
United Kingdom |
|
5 |
USD 1.50 B
|
July 31, 2024 | USD 25.30 | -1.17% |
|
United Kingdom |
|
6 |
USD 1.41 B
|
Dec. 31, 2023 | USD 28.38 | -0.06% |
|
United Kingdom |
|
7 |
USD 1.27 B
|
March 31, 2024 | USD 37.51 | -0.51% |
|
United Kingdom |
|
8 |
USD 1.20 B
|
Dec. 31, 2023 | USD 3.02 | -1.33% |
|
United Kingdom |
|
9 |
USD 841.07 M
|
Sept. 30, 2024 | USD 56.22 | -0.33% |
|
United Kingdom |
|
10 |
USD 771.25 M
|
Dec. 31, 2023 | USD 49.95 | -1.36% |
|
United Kingdom |
|
11 |
USD 662.37 M
|
Dec. 31, 2023 | USD 2.89 | -0.48% |
|
United Kingdom |
|
12 |
USD 248.39 M
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
13 |
USD 133.62 M
|
Dec. 31, 2023 | USD 0.76 | 0.22% |
|
United Kingdom |
|
14 |
USD 109.23 M
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
15 |
USD 50.55 M
|
Dec. 31, 2023 | USD 5.04 | -2.51% |
|
United Kingdom |
|
16 |
USD 49.68 M
|
Dec. 31, 2023 | USD 1.42 | -3.02% |
|
United Kingdom |
|
17 |
USD 47.55 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
18 |
USD 37.64 M
|
June 30, 2024 | USD 0.07 | -16.83% |
|
United Kingdom |
|
19 |
USD 32.90 M
|
Dec. 31, 2023 | USD 1.98 | 0.38% |
|
United Kingdom |
|
20 |
USD 30.36 M
|
Dec. 31, 2023 | USD 0.32 | 2.99% |
|
United Kingdom |
|
21 |
USD 22.37 M
|
March 31, 2024 | USD 0.09 | -6.74% |
|
United Kingdom |
|
22 |
USD 20.51 M
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
23 |
USD 20.49 M
|
April 30, 2024 | USD 0.65 | -1.49% |
|
United Kingdom |
|
24 |
USD 19.47 M
|
Dec. 31, 2023 | USD 0.23 | 1.77% |
|
United Kingdom |
|
25 |
USD 19.16 M
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
26 |
USD 15.91 M
|
June 30, 2024 | USD 38.56 | 0.38% |
|
United Kingdom |
|
27 |
USD 14.31 M
|
Dec. 31, 2023 | USD 0.59 | 0.38% |
|
United Kingdom |
|
28 |
USD 13.74 M
|
Dec. 31, 2023 | USD 0.57 | 0.38% |
|
United Kingdom |
|
29 |
USD 13.25 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
30 |
USD 8.70 M
|
Dec. 31, 2023 | USD 0.16 | 0.38% |
|
United Kingdom |
|
31 |
USD 7.43 M
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
32 |
USD 6.85 M
|
Dec. 31, 2023 | USD 16.92 | 0.06% |
|
United Kingdom |
|
33 |
USD 5.82 M
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
34 |
USD 5.12 M
|
Dec. 31, 2023 | USD 0.03 | -3.20% |
|
United Kingdom |
|
35 |
USD 3.63 M
|
Sept. 30, 2024 | USD 0.16 | 4.56% |
|
United Kingdom |
|
36 |
USD 2.26 M
|
Dec. 31, 2023 | USD 0.20 | -2.58% |
|
United Kingdom |
|
37 |
USD 1.30 M
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
38 |
USD 1.01 M
|
Dec. 31, 2023 | USD 0.05 | 0.38% |
|
United Kingdom |
|
39 |
USD 1.00 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
40 |
USD 864.52 K
|
June 30, 2024 | USD 0.22 | 1.80% |
|
United Kingdom |
|
41 |
USD 634.12 K
|
June 30, 2024 | USD 0.03 | 1.77% |
|
United Kingdom |
|
42 |
USD 432.59 K
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
43 |
USD 254.47 K
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
44 |
USD 184.56 K
|
May 31, 2024 | USD 0.24 | 1.95% |
|
United Kingdom |
|
45 |
USD 95.42 K
|
Dec. 31, 2023 | USD 0.21 | 3.52% |
|
United Kingdom |
|
46 |
USD 50.59 K
|
March 31, 2024 | USD 1.69 | NA |
|
United Kingdom |
|
47 |
USD 10.57 K
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
48 |
USD -1.27 K
|
June 30, 2024 | USD 0.25 | 0.38% |
|
United Kingdom |
|
49 |
USD -1.32 K
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
50 |
USD -4.00 K
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Gross Profit is AstraZeneca PLC (LSE: AZN.L) at USD 37.77 B.
The Healthcare company in United Kingdom with the lowest Gross Profit is Autolus Therapeutics plc (NasdaqGS: AUTL) at USD -4.87 M.
The top 10 Healthcare companies in United Kingdom by Gross Profit are AstraZeneca PLC, GSK plc, Haleon plc, Smith & Nephew plc, Smiths Group plc, Hikma Pharmaceuticals PLC, Halma plc, ConvaTec Group Plc, Diploma PLC and LivaNova PLC.
The bottom 10 Healthcare companies in United Kingdom by Gross Profit are Autolus Therapeutics plc, Scancell Holdings plc, Physiomics Plc, Hemogenyx Pharmaceuticals Plc, Verona Pharma plc, ANGLE plc, Fusion Antibodies plc, COMPASS Pathways plc, Synairgen plc and Poolbeg Pharma PLC.